Analyst
MD
Equibles does not estimate personal net worth.
Nilesh is recorded as Analyst at MD. Nilesh has spoken on 1 earnings call across 1 company, most recently for Lupin Limited on August 7, 2026. The companies whose calls Nilesh spoke on are classified in the Healthcare sector.
“So I think there's three avenues of proprietary products. One is an internal pipeline. So we're building those internally. Another is in licensing deals, as you talked.”
MD
Analyst
Transcript header (unverified)
Lupin Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Lupin Limited
